Preferential amplification of pathogenic sequences

8Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The application of next generation sequencing (NGS) technology in the diagnosis of human pathogens is hindered by the fact that pathogenic sequences, especially viral, are often scarce in human clinical specimens. This known disproportion leads to the requirement of subsequent deep sequencing and extensive bioinformatics analysis. Here we report a method we called Preferential Amplification of Pathogenic Sequences (PATHseq) that can be used to greatly enrich pathogenic sequences. Using a computer program, we developed 8-, 9-, and 10-mer oligonucleotides called non-human primers that do not match the most abundant human transcripts, but instead selectively match transcripts of human pathogens. Instead of using random primers in the construction of cDNA libraries, the PATHseq method recruits these short non-human primers, which in turn, preferentially amplifies non-human, presumably pathogenic sequences. Using this method, we were able to enrich pathogenic sequences uptO 200-fold in the final sequencing library. This method does not require prior knowledge of the pathogen or assumption of the infection; therefore, it provides a fast and sequence-independent approach for detection and identification of human viruses and other pathogens. The PATHseq method, coupled with NGS technology, can be broadly used in identification of known human pathogens and discovery of new pathogens.

Cite

CITATION STYLE

APA

Ge, F., Parker, J., Chul Choi, S., Layer, M., Ross, K., Jilly, B., & Chen, J. (2015). Preferential amplification of pathogenic sequences. Scientific Reports, 5. https://doi.org/10.1038/srep11047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free